Reta is a synthetic research peptide designed to act as a triple receptor agonist, targeting the GLP-1, GIP, and glucagon receptors
Gastroparesis (Stomach Paralysis) Gastroparesis, commonly referred to as stomach paralysis, is a medical condition in which the stomach muscles no longer move food through the digestive tract at a normal rate
But the trade-off, maintaining or even gaining muscle while losing fat, makes it worth the patience for the right individual
Our findings provide new insights on the interaction between metformin and GLP-1, and provide important information for designing new GLP-1-based therapy strategies in treating type 2 diabetes
It works by mimicking incretin hormones, which play a role in regulating blood sugar and appetite, offering promising results in clinical trials for weight reduction